In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

261

HTML

2294

Figures (1-4)

174

Tables (1-1)

123

Sum=2852

Nov 28, 2007 (publication date) through Jul 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Nov 28, 2007; 13(44): 5944-5950
Published online Nov 28, 2007. doi: 10.3748/wjg.v13.i44.5944

Full Size Figure Download Figure

Figure 3 FACS analysis of the phenotypes of H22, DCLptn and DCLptn/H22 fusion cells.

Citation: Sheng XL, Zhang H. In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells. World J Gastroenterol 2007; 13(44): 5944-5950
URL: https://www.wjgnet.com/1007-9327/full/v13/i44/5944.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i44.5944